Japan To Cut Drug Prices in April
This article was originally published in PharmAsia News
Executive Summary
TOKYO - In the beginning of March, Japan's Ministry of Health, Labour and Welfare plans to release a full list of drugs that will be repriced starting in April. The average price cut is expected to be roughly 5.2 percent and includes top-selling prescription drugs
You may also be interested in...
Japan To Lower Price Of Eight Drugs From Takeda, Novartis, BMS And Chugai By 12-18 Percent
As part of an ongoing re-pricing policy for drugs that have seen expanded market share, Japan's Ministry of Health, Labor and Welfare has decided to lower the price on eight drugs effective April 1
Japan To Lower Price Of Eight Drugs From Takeda, Novartis, BMS And Chugai By 12-18 Percent
As part of an ongoing re-pricing policy for drugs that have seen expanded market share, Japan's Ministry of Health, Labor and Welfare has decided to lower the price on eight drugs effective April 1
Japan's Medical Insurance Agency Considers Lowering Combo Drug Prices
Japan's Drug Pricing Committee of the Central Medical Insurance Agency [Chuikyo] considered a proposal July 15 to revise the current pricing formula for combination drugs, and some angiotensin II receptor blockers combined with diuretics could see prices lowered by as much as 30 percent in Japan